Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrenceGENOME MEDICINEIF11.22023-09-1832OAAI
Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology modelJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-0227OAAI
HIGH-DIMENSIONAL IMAGE CYTOMETRY REVEALS SPATIALLY ORGANIZED TUMOR-IMMUNE MICROENVIRONMENT IN HEPATOCELLULAR CARCINOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-101OA
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP modelJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-08-2739OAAI